Original language | English (US) |
---|---|
Pages (from-to) | e486-e487 |
Journal | Critical care medicine |
Volume | 52 |
Issue number | 9 |
DOIs | |
State | Published - Sep 1 2024 |
Funding
Supported by the Society of Critical Care Medicine. Supported by the Society of Critical Care Medicine. Drs. Miano, Sakhuja, Barreto, and Ablordeppey received funding from the National Institutes of Health (K08DK124658 to Dr. Miano; 7K08DK131286 and K08KD131286 to Dr. Sakhuja; K23AI143882 to Dr. Barreto; and 5K01HL161026 to Dr. Ablordeppey). Additionally, Dr. Barreto consults for Wolters Kluwer on topics unrelated to the content of this article. Dr. Martin consults for Nestle, AstraZeneca, and FloBio on topics unrelated to the content of this article. Dr. Basu is a consultant and/ or advisory board member for BioPorto Diagnostics, Biomerieux, Potrero, and Seastar Therapeutics; he receives personal fees. Dr. Sakhuja received funding from the Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition. The remaining authors have disclosed that they do not have any potential conflicts of interest. Drs. Miano, Sakhuja, Barreto, and Ablordeppey received funding from the National Institutes of Health (K08DK124658 to Dr. Miano; 7K08DK131286 and K08KD131286 to Dr. Sakhuja; K23AI143882 to Dr. Barreto; and 5K01HL161026 to Dr. Ablordeppey). Additionally, Dr. Barreto consults for Wolters Kluwer on topics unrelated to the content of this article. Dr. Martin consults for Nestle, AstraZeneca, and FloBio on topics unrelated to the content of this article. Dr. Basu is a consultant and/or advisory board member for BioPorto Diagnostics, Biomerieux, Potrero, and Seastar Therapeutics; he receives personal fees. Dr. Sakhuja received funding from the Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition. The remaining authors have disclosed that they do not have any potential conflicts of interest.
ASJC Scopus subject areas
- Critical Care and Intensive Care Medicine